Equity Analysis

Company News

    Hikal Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    524735
    INE475B01022
    97.5874153
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    HIKAL
    63.59
    4735.98
    EPS(TTM)
    Face Value()
    Div & Yield %:
    6.04
    2
    0.31
     
GEE Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 15,2024
Pursuant to Regulation 30 and 47 read with Schedule III of SEBI (LODR) Regulations 2015 please find enclosed copy of newspaper publication in the following newspapers with respect to unaudited Financial Results for the quarter and half-year ended September 30 2024 approved at the meeting of Board of Directors held on November 14 2024: 1. Business Standard 2. Navakal